UPDATE : Monday, December 16, 2019
상단여백
Voluntary nullifications of drug license tripled in H1 by Lee Hye-seon 2019-06-26 14:25
Seoul Pharma to export erectile dysfunction treatment to Azerbaijan by Lee Han-soo 2019-06-26 13:58
Novartis’ Tasigna confirms long-term success for chronic myelogenous leukemia by Lee Han-soo 2019-06-26 11:39
Huons Global launches new BTX in Korea by Lee Han-soo 2019-06-26 10:52
Hanmi, Sanofi revise accord on co-developing diabetes drug by Lee Han-soo 2019-06-25 17:36
라인
‘Imbruvica raised survival rate of mantle cell lymphoma patients’ by Kim Yun-mi 2019-06-25 15:34
CHA Biotech to transfer SCRMI’s shares, technology to AIRM by Lee Han-soo 2019-06-25 15:25
Regulator OKs P3 trial for Eisai's Alzheimer treatment by Lee Han-soo 2019-06-25 14:09
Novartis’ Cosentyx shows durable, comprehensive treatment for psoriatic disease by Lee Han-soo 2019-06-25 14:09
Celltrion denies delay in local license application for HIV drug Temixys by Lee Hye-seon 2019-06-25 10:56
라인
Latecomer experimental drug no better than Dupixent in trial by Kim Yun-mi 2019-06-24 15:49
Daewoong wins new indications for Nabota by Lee Han-soo 2019-06-24 14:47
Kang Stem Biotech completes P3 trials for stem cell-based atopy treatment by Lee Han-soo 2019-06-24 12:19
Anti-cancer Sutene could cause central nervous system abnormality in fetus by Lee Hye-seon 2019-06-24 11:35
Boryung calls off ₩83-billion supply contract in Jordan by Lee Han-soo 2019-06-21 18:00
라인
MSD’s antibiotic Zerbaxa fails to get insurance coverage by Kim Eun-young 2019-06-21 14:13
‘Customized strategies needed for fast-changing Chinese drug regulation’ by Jeong Sae-im 2019-06-21 14:12
Off-label use of Mabthera Inj. denied by Kim Yun-mi 2019-06-20 15:49
‘Korean cancer researchers have risen to world-class level’ by Kim Yun-mi 2019-06-20 15:04
AbbVie unveils data from upadacitinib phase-3 studies of rheumatoid arthritis by Lee Han-soo 2019-06-19 16:27
여백
여백
여백
Back to Top